Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Accounting Officer

President and CEO

Executive Chairman

Chief People Officer

Chief Legal Officer

Chief Development Officer

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-04-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-04-01	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-03-07	Premium	acquired	Premium	Premium	Premium	-
2024-03-05	Premium	acquired	Premium	Premium	Premium	-
2024-03-05	Premium	sold	Premium	Premium	Premium	-
2024-03-05	Premium	acquired	Premium	Premium	Premium	-
2024-03-04	Premium	sold	Premium	Premium	Premium	-
2024-03-04	Premium	acquired	Premium	Premium	Premium	-
2024-03-01	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-01	Premium	sold	Premium	Premium	Premium	Executive Chairman
2024-03-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Executive Chairman
2024-02-15	Premium	sold	Premium	Premium	Premium	Executive Chairman
2024-02-15	Premium	sold	Premium	Premium	Premium	President and CEO
2024-02-15	Premium	sold	Premium	Premium	Premium	Chief People Officer
2024-02-07	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-02-07	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-02-06	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-02-06	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-02-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-01	Premium	sold	Premium	Premium	Premium	President and CEO
2024-02-01	Premium	sold	Premium	Premium	Premium	Executive Chairman
2024-02-01	Premium	sold (taxes)	Premium	Premium	Premium	Executive Chairman

FOLD - Amicus Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for FOLD